BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nguyen KT, Steel J, Vanounou T, Tsung A, Marsh JW, Geller DA, Gamblin TC. Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection? Ann Surg Oncol 2009;16:3308-15. [PMID: 19774418 DOI: 10.1245/s10434-009-0701-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Ma KW, Cheung TT, She WH, Chok KSH, Chan ACY, Dai WC, Chiu WH, Lo CM. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer. World J Surg 2018;42:823-34. [PMID: 28905105 DOI: 10.1007/s00268-017-4192-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
2 Chatelain D, Farges O, Fuks D, Trouillet N, Pruvot FR, Regimbeau J. Assessment of pathology reports on hilar cholangiocarcinoma: The results of a nationwide, multicenter survey performed by the AFC-HC-2009 study group. Journal of Hepatology 2012;56:1121-8. [DOI: 10.1016/j.jhep.2011.12.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
3 Matsuo K, Rocha FG, Ito K, D’Angelica MI, Allen PJ, Fong Y, Dematteo RP, Gonen M, Endo I, Jarnagin WR. The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg. 2012;215:343-355. [PMID: 22749003 DOI: 10.1016/j.jamcollsurg.2012.05.025] [Cited by in Crossref: 126] [Cited by in F6Publishing: 110] [Article Influence: 14.0] [Reference Citation Analysis]
4 Boland B, Kim A, Nissen N, Colquhoun S. Cholangiocarcinoma: Aggressive Surgical Intervention Remains Justified. The American Surgeon 2012;78:157-60. [DOI: 10.1177/000313481207800231] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Yang Y, Liu Y, He JC, Wang JM, Schemmer P, Ma CQ, Qian YW, Yao W, Zhang J, Qi WP, Fu Y, Feng W, Yang T. 14-3-3ζ and aPKC-ι synergistically facilitate epithelial-mesenchymal transition of cholangiocarcinoma via GSK-3β/Snail signaling pathway. Oncotarget 2016;7:55191-210. [PMID: 27409422 DOI: 10.18632/oncotarget.10483] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
6 Mao K, Liu J, Sun J, Zhang J, Chen J, Pawlik TM, Jacobs LK, Xiao Z, Wang J. Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma. J Gastroenterol Hepatol. 2016;31:417-426. [PMID: 26250532 DOI: 10.1111/jgh.13072] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
7 Cheng QB, Yi B, Wang JH, Jiang XQ, Luo XJ, Liu C, Ran RZ, Yan PN, Zhang BH. Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV. Eur J Surg Oncol. 2012;38:1197-1203. [PMID: 22992326 DOI: 10.1016/j.ejso.2012.08.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
8 Amini A, Gamblin TC. Palliation: treating patients with inoperable biliary tract and primary liver tumors. Surg Oncol Clin N Am. 2014;23:383-397. [PMID: 24560116 DOI: 10.1016/j.soc.2013.10.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
9 Chen TC, Jan YY, Yeh TS. K-ras mutation is strongly associated with perineural invasion and represents an independent prognostic factor of intrahepatic cholangiocarcinoma after hepatectomy. Ann Surg Oncol. 2012;19 Suppl 3:S675-S681. [PMID: 22805857 DOI: 10.1245/s10434-012-2224-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
10 Lee JH, Hwang DW, Lee SY, Park K, Lee Y. The Proximal Margin of Resected Hilar Cholangiocarcinoma: The Effect of Microscopic Positive Margin on Long-Term Survival. The American Surgeon 2012;78:471-7. [DOI: 10.1177/000313481207800440] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wang X, Hu KB, Zhang YQ, Yang CJ, Yao HH. Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma. Cancer Biomark 2018;23:549-59. [PMID: 30452401 DOI: 10.3233/CBM-181684] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
12 Huang H, Wan X, Bai Y, Bian J, Xiong J, Xu Y, Sang X, Zhao H. Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of T stages in hilar cholangiocarcinoma. Cancer Manag Res. 2019;11:5157-5162. [PMID: 31239770 DOI: 10.2147/cmar.s192532] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
13 Tan XY, Chang S, Liu W, Tang HH. Silencing of CXCR4 inhibits tumor cell proliferation and neural invasion in human hilar cholangiocarcinoma. Gut Liver 2014;8:196-204. [PMID: 24672662 DOI: 10.5009/gnl.2014.8.2.196] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
14 Saleh M, Virarkar M, Bura V, Valenzuela R, Javadi S, Szklaruk J, Bhosale P. Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings. Abdom Radiol (NY) 2020;45:3662-80. [PMID: 32417933 DOI: 10.1007/s00261-020-02559-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 He JC, Yao W, Wang JM, Schemmer P, Yang Y, Liu Y, Qian YW, Qi WP, Zhang J, Shen Q, Yang T. TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors. Oncotarget 2016;7:75441-56. [PMID: 27705912 DOI: 10.18632/oncotarget.12254] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
16 Kamachi H, Kamiyama T, Tsuruga Y, Orimo T, Wakayama K, Shimada S, Kakisaka T, Yokoo H, Yamashita K, Taketomi A. Transparenchymal glissonean approach: a novel surgical technique for advanced perihilar bile duct cancer. Langenbecks Arch Surg 2018;403:387-94. [PMID: 29063245 DOI: 10.1007/s00423-017-1633-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Qian Y, Yao W, Yang T, Yang Y, Liu Y, Shen Q, Zhang J, Qi W, Wang J. aPKC-ι/P-Sp1/Snail signaling induces epithelial-mesenchymal transition and immunosuppression in cholangiocarcinoma. Hepatology 2017;66:1165-82. [DOI: 10.1002/hep.29296] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 10.5] [Reference Citation Analysis]
18 Brown KM, Parmar AD, Geller DA. Intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am. 2014;23:231-246. [PMID: 24560108 DOI: 10.1016/j.soc.2013.10.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
19 Bergquist JR, Groeschl RT, Ivanics T, Shubert CR, Habermann EB, Kendrick ML, Farnell MB, Nagorney DM, Truty MJ, Smoot RL. Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics. HPB (Oxford). 2016;18:886-892. [PMID: 27546172 DOI: 10.1016/j.hpb.2016.07.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
20 Groeschl RT, Turaga KK, Gamblin TC. Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma. J Surg Oncol. 2013;107:608-612. [PMID: 23386397 DOI: 10.1002/jso.23289] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 6.5] [Reference Citation Analysis]
21 Ratti F, Cipriani F, Ariotti R, Gagliano A, Paganelli M, Catena M, Aldrighetti L. Safety and feasibility of laparoscopic liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma: a propensity score-based case-matched analysis from a single institution. Surg Endosc 2016;30:1999-2010. [DOI: 10.1007/s00464-015-4430-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
22 Huang XT, Cai JP, Chen W, Huang CS, Li JH, Gan TT, Liang LJ, Yin XY. Establishment and validation of a nomogram for predicting overall survival of node-negative perihilar cholangiocarcinoma. Asian J Surg 2021:S1015-9584(21)00456-5. [PMID: 34384677 DOI: 10.1016/j.asjsur.2021.07.039] [Reference Citation Analysis]
23 Hu HJ, Jin YW, Shrestha A, Ma WJ, Wang JK, Liu F, Zhu YY, Zhou RX, Regmi P, Cheng NS, Li FY. Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China. Cancer Med 2019;8:1567-75. [PMID: 30868740 DOI: 10.1002/cam4.2052] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]